AR056721A1 - Preparado farmaceutico oral estabilizado que contiene clopidogrel bisulfato - Google Patents
Preparado farmaceutico oral estabilizado que contiene clopidogrel bisulfatoInfo
- Publication number
- AR056721A1 AR056721A1 ARP060104644A ARP060104644A AR056721A1 AR 056721 A1 AR056721 A1 AR 056721A1 AR P060104644 A ARP060104644 A AR P060104644A AR P060104644 A ARP060104644 A AR P060104644A AR 056721 A1 AR056721 A1 AR 056721A1
- Authority
- AR
- Argentina
- Prior art keywords
- bisulfato
- oral pharmaceutical
- pharmaceutical containing
- stabilized oral
- containing clopidogrel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050100460A KR20070044323A (ko) | 2005-10-24 | 2005-10-24 | 보관안정성이 개선된 클로피도그렐 황산수소염 함유 경구용제제 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR056721A1 true AR056721A1 (es) | 2007-10-17 |
Family
ID=37967949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060104644A AR056721A1 (es) | 2005-10-24 | 2006-10-24 | Preparado farmaceutico oral estabilizado que contiene clopidogrel bisulfato |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR20070044323A (fr) |
AR (1) | AR056721A1 (fr) |
TW (1) | TW200727898A (fr) |
WO (1) | WO2007049868A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY164765A (en) * | 2007-10-10 | 2018-01-30 | Avantor Performance Mat Llc | Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof |
ES2376057T3 (es) | 2008-02-26 | 2012-03-08 | Laboratorios Lesvi, S.L. | Formulaciones farmacéuticas que contienen clopidogrel. |
KR101324862B1 (ko) * | 2011-07-12 | 2013-11-01 | (주)에이에스텍 | 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법 |
HUP1400294A2 (hu) | 2014-06-13 | 2015-12-28 | Skillpharm Kft | Clopidogrel új alkalmazása |
CN109528669A (zh) * | 2018-12-25 | 2019-03-29 | 哈尔滨珍宝制药有限公司 | 硫酸氢氯吡格雷组合物、硫酸氢氯吡格雷片剂及其制备方法 |
CN112999180B (zh) * | 2019-12-20 | 2022-08-30 | 青岛黄海制药有限责任公司 | 一种硫酸氢氯吡格雷晶型ⅱ片剂及其制备方法 |
CN111166745A (zh) * | 2020-01-19 | 2020-05-19 | 成都施贝康生物医药科技有限公司 | 含消旋氧吡格雷或其盐的组合物及应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2792836B3 (fr) * | 1999-04-30 | 2001-07-27 | Sanofi Sa | Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel |
CA2363053C (fr) * | 2001-11-09 | 2011-01-25 | Bernard Charles Sherman | Formulation pour pastilles de bisulfate de clopidogrel |
WO2005070464A2 (fr) * | 2004-01-21 | 2005-08-04 | Biofarma Ilac Sanayi Ve Ticaret A.S. | Formulation de comprimes de bisulfate de clopidogrel |
-
2005
- 2005-10-24 KR KR1020050100460A patent/KR20070044323A/ko not_active Application Discontinuation
-
2006
- 2006-10-09 WO PCT/KR2006/004046 patent/WO2007049868A1/fr active Application Filing
- 2006-10-23 TW TW095138977A patent/TW200727898A/zh unknown
- 2006-10-24 AR ARP060104644A patent/AR056721A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2007049868A1 (fr) | 2007-05-03 |
TW200727898A (en) | 2007-08-01 |
KR20070044323A (ko) | 2007-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR056721A1 (es) | Preparado farmaceutico oral estabilizado que contiene clopidogrel bisulfato | |
ECSP088082A (es) | Derivados de piridazina | |
TW200628161A (en) | Novel betulin derivatives, preparation thereof and use thereof | |
TW200732303A (en) | Novel fused pyrrole derivatives | |
TW200740764A (en) | Pyrazolone derivatives | |
MY138941A (en) | Aryl-pyridine derivatives | |
AR064692A1 (es) | Derivados de oxindol sustituido medicamentos que los comprenden y uso de los mismos | |
TW200616976A (en) | Pyrimidine derivatives | |
BRPI0717035B8 (pt) | moduladores de benzotriazol cinase | |
SG148178A1 (en) | Indozolone derivatives as 11b-hsd1 inhibitors | |
ATE520406T1 (de) | Kristalline form des ibandronat-natriums | |
TW200616940A (en) | Novel hexafluoroisopropanol substituted ether derivatives | |
MX2010005824A (es) | Derivados de aminotiazol. | |
MX2009010567A (es) | Derivados de imidazolidinona. | |
BRPI0512677A2 (pt) | derivados de quinazolina | |
TW200633963A (en) | Novel cyclohexane derivatives | |
DE60319707D1 (de) | Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose | |
MX2009007416A (es) | Derivados de sulfonamida como inhibidores de quimasa. | |
BR0114156A (pt) | Forma amorfa de inibidor de ciclo de célula | |
DE60236025D1 (de) | Pharmazeutische zusammensetzung enthaltend l-arginin | |
BRPI0411087A (pt) | aperfeiçoamentos em ou relacionados a compostos orgánicos | |
BRPI0510704A (pt) | tienopiridazinas como inibidores de ikk | |
AR042674A1 (es) | [4-( 3-aminometilfenil) piperidin-1-il] - [5-(2-fluorofeniletinil) furan-2-il] -metanona como un inhibidor de triptasa de celulas mast | |
MX2009003640A (es) | Derivados de acidos vinilogos como inhibidores de quimasa. | |
TH102540S (th) | กล่องบรรจุ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |